These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 12239580)
21. SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism. Pingault V; Girard M; Bondurand N; Dorkins H; Van Maldergem L; Mowat D; Shimotake T; Verma I; Baumann C; Goossens M Hum Genet; 2002 Aug; 111(2):198-206. PubMed ID: 12189494 [TBL] [Abstract][Full Text] [Related]
22. TTF-1 and RET promoter SNPs: regulation of RET transcription in Hirschsprung's disease. Garcia-Barcelo M; Ganster RW; Lui VC; Leon TY; So MT; Lau AM; Fu M; Sham MH; Knight J; Zannini MS; Sham PC; Tam PK Hum Mol Genet; 2005 Jan; 14(2):191-204. PubMed ID: 15548547 [TBL] [Abstract][Full Text] [Related]
23. Analysis of SOX10 mutations identified in Waardenburg-Hirschsprung patients: Differential effects on target gene regulation. Chan KK; Wong CK; Lui VC; Tam PK; Sham MH J Cell Biochem; 2003 Oct; 90(3):573-85. PubMed ID: 14523991 [TBL] [Abstract][Full Text] [Related]
24. Japanese patients with sporadic Hirschsprung: mutation analysis of the receptor tyrosine kinase proto-oncogene, endothelin-B receptor, endothelin-3, glial cell line-derived neurotrophic factor and neurturin genes: a comparison with similar studies. Sakai T; Nirasawa Y; Itoh Y; Wakizaka A Eur J Pediatr; 2000 Mar; 159(3):160-7. PubMed ID: 10664228 [TBL] [Abstract][Full Text] [Related]
25. Interactions between Sox10 and EdnrB modulate penetrance and severity of aganglionosis in the Sox10Dom mouse model of Hirschsprung disease. Cantrell VA; Owens SE; Chandler RL; Airey DC; Bradley KM; Smith JR; Southard-Smith EM Hum Mol Genet; 2004 Oct; 13(19):2289-301. PubMed ID: 15294878 [TBL] [Abstract][Full Text] [Related]
26. Functional haplotypes of the RET proto-oncogene promoter are associated with Hirschsprung disease (HSCR). Fitze G; Appelt H; König IR; Görgens H; Stein U; Walther W; Gossen M; Schreiber M; Ziegler A; Roesner D; Schackert HK Hum Mol Genet; 2003 Dec; 12(24):3207-14. PubMed ID: 14600022 [TBL] [Abstract][Full Text] [Related]
27. Contribution of RET, NTRK3 and EDN3 to the expression of Hirschsprung disease in a multiplex family. Sánchez-Mejías A; Fernández RM; López-Alonso M; Antiñolo G; Borrego S J Med Genet; 2009 Dec; 46(12):862-4. PubMed ID: 19556619 [TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in the genes encoding the 4 RET ligands, GDNF, NTN, ARTN, PSPN, and susceptibility to Hirschsprung disease. Fernandez RM; Ruiz-Ferrer M; Lopez-Alonso M; Antiñolo G; Borrego S J Pediatr Surg; 2008 Nov; 43(11):2042-7. PubMed ID: 18970938 [TBL] [Abstract][Full Text] [Related]
30. L1cam acts as a modifier gene during enteric nervous system development. Wallace AS; Schmidt C; Schachner M; Wegner M; Anderson RB Neurobiol Dis; 2010 Dec; 40(3):622-33. PubMed ID: 20696247 [TBL] [Abstract][Full Text] [Related]
31. Hirschsprung's disease as a model of complex genetic etiology. Borrego S; Ruiz-Ferrer M; Fernández RM; Antiñolo G Histol Histopathol; 2013 Sep; 28(9):1117-36. PubMed ID: 23605783 [TBL] [Abstract][Full Text] [Related]
32. Analysis of RET, ZEB2, EDN3 and GDNF genomic rearrangements in central congenital hyperventilation syndrome patients by multiplex ligation-dependent probe amplification. Serra A; Görgens H; Alhadad K; Fitze G; Schackert HK Ann Hum Genet; 2010 Jul; 74(4):369-74. PubMed ID: 20456320 [TBL] [Abstract][Full Text] [Related]
33. Allele dosage-dependent penetrance of RET proto-oncogene in an Israeli-Arab inbred family segregating Hirschsprung disease. Basel-Vanagaite L; Pelet A; Steiner Z; Munnich A; Rozenbach Y; Shohat M; Lyonnet S Eur J Hum Genet; 2007 Feb; 15(2):242-5. PubMed ID: 17091122 [TBL] [Abstract][Full Text] [Related]
34. Point nucleotidic changes in both the RET proto-oncogene and the endothelin-B receptor gene in a Hirschsprung disease patient associated with Down syndrome. Sakai T; Wakizaka A; Nirasawa Y; Ito Y Tohoku J Exp Med; 1999 Jan; 187(1):43-7. PubMed ID: 10458491 [TBL] [Abstract][Full Text] [Related]
35. Mutations and polymorphisms of Hirschsprung disease candidate genes in Thai patients. Sangkhathat S; Kusafuka T; Chengkriwate P; Patrapinyokul S; Sangthong B; Fukuzawa M J Hum Genet; 2006; 51(12):1126-1132. PubMed ID: 17009072 [TBL] [Abstract][Full Text] [Related]
36. A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Emison ES; McCallion AS; Kashuk CS; Bush RT; Grice E; Lin S; Portnoy ME; Cutler DJ; Green ED; Chakravarti A Nature; 2005 Apr; 434(7035):857-63. PubMed ID: 15829955 [TBL] [Abstract][Full Text] [Related]
37. Low RET mutation frequency and polymorphism analysis of the RET and EDNRB genes in patients with Hirschsprung disease in Taiwan. Wu TT; Tsai TW; Chu CT; Lee ZF; Hung CM; Su CC; Li SY; Hsieh M; Li C J Hum Genet; 2005; 50(4):168-174. PubMed ID: 15834508 [TBL] [Abstract][Full Text] [Related]
38. De novo mutation of GDNF, ligand for the RET/GDNFR-alpha receptor complex, in Hirschsprung disease. Ivanchuk SM; Myers SM; Eng C; Mulligan LM Hum Mol Genet; 1996 Dec; 5(12):2023-6. PubMed ID: 8968758 [TBL] [Abstract][Full Text] [Related]
39. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Attié T; Pelet A; Edery P; Eng C; Mulligan LM; Amiel J; Boutrand L; Beldjord C; Nihoul-Fékété C; Munnich A Hum Mol Genet; 1995 Aug; 4(8):1381-6. PubMed ID: 7581377 [TBL] [Abstract][Full Text] [Related]
40. Familial form of hirschsprung disease: nucleotide sequence studies reveal point mutations in the RET proto-oncogene in two of six families but not in other candidate genes. Munnes M; Fanaei S; Schmitz B; Muiznieks I; Holschneider AM; Doerfler W Am J Med Genet; 2000 Sep; 94(1):19-27. PubMed ID: 10982477 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]